Ignite Creation Date:
2024-05-06 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 1:54 PM
Study NCT ID:
NCT04709224
Status:
COMPLETED
Last Update Posted:
2022-12-05
First Post:
2020-12-29
Brief Title:
Pharmacokinetics Safety and Tolerability of Lumateperone Long-Acting Injectable in Patients With Schizophrenia
Sponsor:
Intra-Cellular Therapies Inc
Organization:
Intra-Cellular Therapies Inc
Organization Data
Organization:
Intra-Cellular Therapies Inc
Class:
INDUSTRY
Study ID:
ITI-007-025
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Intra-Cellular Therapies Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None